Pison Technology Inc, a Boston-based application focused on the biopotential company, has now secured a $7 million in Series A funding round.
Pison Technology is founded by Dexter Ang in the year 2016. It is an application-focused biopotential company whose technology unlocks access to the physical and digital world by leveraging neurological insights, and its insights platform supports innovations in sports performance, medicine, and general wellness.
The company has partnered in development with Microsoft, Google, Boston Dynamics, Samsung, Mitsubishi Electric, and others.
“Our technology was developed to help ALS patients control digital interfaces by just thinking of their intended movement. What began as a mission to help patients navigate the world made smaller by disability has evolved into a world-class platform that connects neurological output with today’s digital world,” Dexter Ang, Pison CEO. “The next phase for Pison will be releasing our gesture technology to improve lives, safety, and productivity across multiple industries.”
“We are very excited by the team and the early product development and where Pison can take the functionality. Pison’s early success at harnessing neuromuscular sensing capabilities is breathtaking. In keeping with our focus on deep tech and companies that can find success with commercial requirements, Pison is a perfect fit,” Jim Hunt, Partner, Lavrock Ventures.
Pison Technology latest funding
The round was backed by the Lavrock Ventures with participation from In-Q-Tel, Bose Ventures, and Decisive Point.
The company, as of now, has plans to use the new funds to launch market-ready products, with a series of ecosystem releases beginning in late 2021.